NEWRON PHARMACEUT. EO-20 Capital Reinvestment Ratio
NEWRON PHARMACEUT. EO-20 capital reinvestment ratio. NEWRON PHARMACEUT. EO-20 (NP5) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow (€33.60 Million) in capital expenditures (€31.00K). Check NEWRON PHARMACEUT. EO-20 investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of NEWRON PHARMACEUT. EO-20 (2012–2025)
Capital reinvestment ratio of NEWRON PHARMACEUT. EO-20 from 2012 to 2025. This chart tracks NEWRON PHARMACEUT. EO-20's Capital Reinvestment Ratio across 2 annual periods. Also explore NP5 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
NEWRON PHARMACEUT. EO-20 Capital Reinvestment Ratio by Year (2012–2025)
NEWRON PHARMACEUT. EO-20 capital reinvestment ratio by year from 2012 to 2025. For the full cash flow conversion analysis, see NEWRON PHARMACEUT. EO-20 (NP5) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | €32.56 Million | €47.31K | ▼ -23.1% |
| 2012 | 0.00x | €5.83 Million | €11.00K | — |